Samsung’s Sleep Apnea Feature on Galaxy Watch ‘First of Its Kind’ Authorized by FDA

RIDGEFIELD PARK, New Jersey—Samsung Electronics Co., Ltd. announced that the sleep apnea feature¹ on the Samsung Health Monitor app² has received De Novo authorization from the United States Food and Drug Administration (FDA). This feature, which will detect signs of sleep apnea using a compatible Samsung Galaxy watch and phone, is the first of its kind to be authorized by FDA following previous approval by South Korea’s Ministry of Food and Drug Safety (MFDS), announced last October in South Korea.